[Transitory (presystemic) forms of lupus erythematosus and characteristics of their immunotherapy]

The authors' findings confirm the possibility of such forms. In 16.5% of cases lupus erythematosus transforms from the discoid form and in 6.9% of cases from the disseminated form, immunologically presenting as T- or B-dependent lupus erythematosus. The authors describe immunocorrecting therapy for various forms of the disease, including immunosuppression of T- and B-lymphocytes by the quinoline series drugs or by their combinations with corticosteroids, as well as immunostimulation of T-lymphocytes by the imidazole series drugs or by thymus hormones.